Product Information
FLUOXETINE HCL 40 MG CAPSULE is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.0499 per EA under NDC 72241000910. Its NADAC has been published 134 times since Jan 31, 2024.
FDA first approved this application on May 23, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241000910
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206993FDA Approved
5/23/2019
TE Code
AB1
On Market Since
9/8/2021
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 40 MG CAPSULE has been published 134 times since Jan 31, 2024, and over the history we have for it it has declined 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0499 per EA |
|---|---|
| All-time high | $0.0752 (Feb 14, 2024) |
| All-time low | $0.0453 (Nov 20, 2024) |
| 52-week high | $0.0673 |
| 52-week low | $0.0499 |
| Median price | $0.0633 |
| Average price | $0.0621 |
| Largest weekly change | -35.9% (Nov 20, 2024) |
| Weeks tracked | 134 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 40 MG CAPSULE, manufactured by Modavar Pharmaceuticals LLC, is $0.0499 per EA (NDC 72241000910), effective Aug 19, 2026.
How has the price of FLUOXETINE HCL 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has declined 33.6%. It has been tracked across 134 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 40 MG CAPSULE?
Since Jan 31, 2024, the NADAC for FLUOXETINE HCL 40 MG CAPSULE has ranged from a low of $0.0453 (Nov 20, 2024) to a high of $0.0752 (Feb 14, 2024), with a median of $0.0633 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 40 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUOXETINE HCL 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUOXETINE HCL 40 MG CAPSULE?
FLUOXETINE HCL 40 MG CAPSULE (NDC 72241000910) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.